NEBILET

This brand name is authorized in Australia, Brazil, Croatia, Ecuador, Estonia, Germany, Hong Kong SAR China, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, South Africa, Tunisia, UK.

Active ingredients

The drug NEBILET contains one active pharmaceutical ingredient (API):

1	Nebivolol UNII JGS34J7L9I - NEBIVOLOL HYDROCHLORIDE
	Nebivolol is a racemate of two enantiomers, SRRR-nebivolol (or d-nebivolol) and RSSS-nebivolol (or l-nebivolol). It is a competitive and selective beta-receptor antagonist and it has mild vasodilating properties due to an interaction with the L-arginine/nitric oxide pathway.
	Read more about Nebivolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEBILET Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB12	Nebivolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	9311C, 9312D, 9316H
BR	Câmara de Regulação do Mercado de Medicamentos	504114004115313, 504114008110316, 504116020054503, 504116020054603, 504116020054703
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07371053, 07371076, 07371082, 10039701, 10172920, 13595816
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	363661212
EE	Ravimiamet	1032297, 1072426, 1072437, 1445116, 1445127, 1445138, 1445149, 1445150, 1880210, 1880221, 1880232, 1880243, 1880254, 1880265, 1880276, 1880287
GB	Medicines & Healthcare Products Regulatory Agency	139361, 143301, 16158, 162117, 373485
HK	Department of Health Drug Office	59922, 65104
HR	Agencija za lijekove i medicinske proizvode	HR-H-645496675
IE	Health Products Regulatory Authority	35608, 35653, 54373
LT	Valstybinė vaistų kontrolės tarnyba	1003103, 1005010, 1005395, 1011147, 1011148, 1051639, 1051640, 1051641, 1051643
MT	Medicines Authority	MA204/00201
NL	Z-Index G-Standaard, PRK	46353
PL	Rejestru Produktów Leczniczych	100084850
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W04501001, W04501002, W04501003, W04501004, W04501005, W04501006
SG	Health Sciences Authority	11728P
TN	Direction de la Pharmacie et du Médicament	15463013
ZA	Health Products Regulatory Authority	34/7.1.3/0495